![](/img/cover-not-exists.png)
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial
Fitchett, David, Butler, Javed, van de Borne, Philippe, Zinman, Bernard, Lachin, John M, Wanner, Christoph, Woerle, Hans J, Hantel, Stefan, George, Jyothis T, Johansen, Odd Erik, Inzucchi, Silvio EVolume:
39
Language:
english
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/ehx511
Date:
February, 2018
File:
PDF, 537 KB
english, 2018